Follow Kelso’s Retail Offer via RetailBook here.

Less Ads, More Data, More Tools Register for FREE

DIRECTOR DEALINGS: Oxford BioDynamics Non-Exec's Associate Buys Shares

Fri, 15th Feb 2019 14:55

LONDON (Alliance News) - Oxford BioDynamics PLC on Friday said that the Vulpie Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased nearly GBP37,000 in stock over two transactions on Wednesday and Thursday.

On Wednesday, 17,000 shares were bought at 168.5 pence per share. On Thursday, 5,000 shares were acquired for 168.0p each.

Following these transactions, Vulpie Life Sciences now holds 11.6 million shares in total, reflecting a 13% stake in the company.

Shares in the biotechnology company were down 4.8% at 158.00 pence on Friday.

Oxford Biodyn

Shares in this article

Related News

TRADING UPDATES: Futura Medical's fundraise and formal sale process
3 Sep 2026

TRADING UPDATES: Futura Medical's fundraise and formal sale process

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: JPM Global Core liquidation; IGC shareholder's rebuke
27 Aug 2026

TRADING UPDATES: JPM Global Core liquidation; IGC shareholder's rebuke

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Funds eEnergy Group + 9 more shares